35Pharma
Operator of a biopharmaceutical company intended for pulmonary hypertension and musculoskeletal disorders. The company combines protein engineering expertise with a deep understanding of transforming ...
Valuation
$0
Share Price
N/A
Total Raised
$70M
Last Round
N/A